Shares of Ambu A/S (OTCMKTS:AMBBY – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $20.13 and last traded at $20.13, with a volume of 700 shares. The stock had previously closed at $19.25.
Ambu A/S Price Performance
The firm has a fifty day moving average price of $17.44 and a 200-day moving average price of $16.36. The company has a quick ratio of 1.49, a current ratio of 2.53 and a debt-to-equity ratio of 0.10. The firm has a market cap of $4.73 billion and a price-to-earnings ratio of 100.66.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its earnings results on Tuesday, May 14th. The company reported $0.08 earnings per share for the quarter. Ambu A/S had a return on equity of 6.80% and a net margin of 7.23%. The firm had revenue of $199.06 million for the quarter.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Stories
- Five stocks we like better than Ambu A/S
- Ride Out The Recession With These Dividend Kings
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- The How And Why of Investing in Oil Stocks
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- Best Aerospace Stocks Investing
- Adobe Stock: It’s Not Too Late To Buy The Dip
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
